Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmia

Authors

Ido Goldenberg, Rochester Regional HealthFollow
Mehmet Aktas
Wojciech Zareba
Arwa Younis
Valentina Kutyifa

Department

Medicine

Document Type

Conference Proceeding

Publication Title

Circulation

Conference Name

American Heart Association's 2021 Scientific Sessions

Conference Date

2021-01-01

Abstract

Introduction: Cardiac Resynchronization Therapy (CRT) was shown to be associated with clinically significant benefit by lowering mortality, heart failure hospitalizations, and improving quality of life in patients with reduced left ventricular function and a wide QRS. However, there are conflicting data on the effect of CRT on the risk of ventricular tachycardia or ventricular fibrillation (VT/VF) in implantable cardioverter defibrillator (ICD) recipients.

First Page

A11977

Volume

144

Issue

Suppl_1

Publication Date

11-8-2021

Comments

ELECTROPHYSIOLOGY AND ARRHYTHMIAS

SESSION TITLE: SUDDEN CARDIAC DEATH AND CARDIAC IMPLANTABLE ELECTRONIC DEVICES: WHAT’S NEW IN RISK PREDICTION?

Abstract 11977

Recommended Citation

Goldenberg, I., Aktas, M., Zareba, W., Younis, A., & Kutyifa, V. (2021). Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmia. Circulation, 144 (Suppl_1), A11977. Retrieved from https://scholar.rochesterregional.org/rrhpubs/1267